{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:33:50Z","timestamp":1793136830395,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jmii.2020.12.012","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:39:08Z","timestamp":1610638748000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Emergence of concurrent levofloxacin- and trimethoprim\/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan"],"prefix":"10.1016","volume":"55","author":[{"given":"Rui-Xin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Teng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching Hsun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2020.12.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2004.01.033","article-title":"Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen","volume":"57","author":"Senol","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2020.12.012_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2020.12.012_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14787210.2014.864553","article-title":"New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen","volume":"12","author":"Brooke","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jmii.2020.12.012_bib5","first-page":"297","article-title":"Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review","volume":"31","author":"Andelkovic","year":"2019","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-2007-996414","article-title":"Optimizing therapy for Stenotrophomonas maltophilia","volume":"28","author":"Muder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2020.12.012_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.01682-13","article-title":"Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?","volume":"58","author":"Cho","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib9","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997-2016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1099\/jmm.0.000550","article-title":"Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico","volume":"66","author":"Herrera-Heredia","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2020.12.012_bib11","article-title":"Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China","volume":"11","author":"Hu","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jmii.2020.12.012_bib12","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1016\/j.ijid.2012.04.004","article-title":"Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance","volume":"16","author":"Neela","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/IDR.S194482","article-title":"Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)","volume":"12","author":"Lai","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jmii.2020.12.012_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3346\/jkms.2013.28.1.62","article-title":"Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates","volume":"28","author":"Chung","year":"2013","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.jmii.2020.12.012_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmii.2011.09.028","article-title":"A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan","volume":"45","author":"Wu","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.12.012_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhin.2019.09.001","article-title":"Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients","volume":"104","author":"Wang","year":"2020","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2020.12.012_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmii.2016.12.007","article-title":"Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: a matched case-control study","volume":"50","author":"Wang","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.12.012_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jmii.2013.09.005","article-title":"Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital","volume":"48","author":"Pien","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2020.12.012_bib20","doi-asserted-by":"crossref","first-page":"e00301","DOI":"10.1128\/AAC.00301-18","article-title":"Overexpression of the efflux pumps SmeVWX and SmeDEF is a major cause of resistance to Co-trimoxazole in Stenotrophomonas maltophilia","volume":"62","author":"Sanchez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/mdr.2009.0134","article-title":"Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group","volume":"16","author":"Rafailidis","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2020.12.012_bib22","doi-asserted-by":"crossref","first-page":"e01730","DOI":"10.1128\/AAC.01730-17","article-title":"A systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant enterobacteriaceae","volume":"62","author":"van Loon","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12866-016-0763-y","article-title":"Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India","volume":"16","author":"Mittal","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jmii.2020.12.012_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jamda.2010.06.012","article-title":"Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma","volume":"12","author":"Drinka","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jmii.2020.12.012_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QCO.0b013e328329fa4e","article-title":"Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia","volume":"22","author":"Brito","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1086\/422317","article-title":"Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia","volume":"39","author":"El Solh","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1532-5415.2001.4930270.x","article-title":"Colonization of skilled-care facility residents with antimicrobial-resistant pathogens","volume":"49","author":"Trick","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jmii.2020.12.012_bib28","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/cncr.22705","article-title":"Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer","volume":"109","author":"Ansari","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jmii.2020.12.012_bib29","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1128\/AAC.01723-15","article-title":"Whole-genome sequencing identifies emergence of a quinolone resistance mutation in a case of Stenotrophomonas maltophilia bacteremia","volume":"59","author":"Pak","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib30","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/jac\/dkz326","article-title":"Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia","volume":"74","author":"Blanco","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib31","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections","volume":"54","author":"Farrell","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2017.02.020","article-title":"Antimicrobial activity of tigecycline and cefoperazone\/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)","volume":"88","author":"Pfaller","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2020.12.012_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1179\/1120009X12Z.00000000022","article-title":"Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections","volume":"24","author":"Tekce","year":"2012","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2020.12.012_bib34","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/s41598-019-41308-9","article-title":"Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia","volume":"9","author":"Blanco","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:03Z","timestamp":1761658023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118221000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1684118221000104"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2020.12.012","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of concurrent levofloxacin- and trimethoprim\/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2020.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}